KNTE
State Street’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-61,959
| Closed | -$147K | – | 4420 |
|
|
2023
Q4 | $147K | Hold |
61,959
| – | – | ﹤0.01% | 3961 |
|
|
2023
Q3 | $86.7K | Hold |
61,959
| – | – | ﹤0.01% | 4143 |
|
|
2023
Q2 | $188K | Sell |
61,959
-404,422
| -87% | -$1.23M | ﹤0.01% | 4025 |
|
|
2023
Q1 | $2.91M | Buy |
466,381
+3,199
| +0.7% | +$20K | ﹤0.01% | 3196 |
|
|
2022
Q4 | $2.83M | Sell |
463,182
-3,339
| -0.7% | -$20.4K | ﹤0.01% | 3268 |
|
|
2022
Q3 | $5.58M | Buy |
466,521
+14,243
| +3% | +$170K | ﹤0.01% | 3004 |
|
|
2022
Q2 | $5.7M | Buy |
452,278
+29,124
| +7% | +$367K | ﹤0.01% | 3039 |
|
|
2022
Q1 | $4.77M | Buy |
423,154
+34,224
| +9% | +$385K | ﹤0.01% | 3207 |
|
|
2021
Q4 | $6.89M | Buy |
388,930
+56,355
| +17% | +$999K | ﹤0.01% | 3097 |
|
|
2021
Q3 | $7.66M | Buy |
332,575
+95,445
| +40% | +$2.2M | ﹤0.01% | 3023 |
|
|
2021
Q2 | $5.52M | Buy |
237,130
+53,848
| +29% | +$1.25M | ﹤0.01% | 3191 |
|
|
2021
Q1 | $5.71M | Buy |
+183,282
| New | +$5.71M | ﹤0.01% | 2995 |
|